Raj Singh, M.D., is a board-certified radiation oncologist at the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. He specializes in treating patients with central nervous system cancers, including primary and metastatic cancers involving the brain or spine, head and neck cancers, skin cancers, and thoracic malignancies such as lung cancer. Much of Dr. Singh’s research has focused on stereotactic radiosurgery (SRS) for brain metastases and stereotactic ablative radiation therapy (SABR) for metastatic disease outside of the brain. He has a particular interest in determining the specific patient populations that benefit the most from aggressive local therapy based on the original cancer type and other patient and tumor characteristics. Dr. Singh also has published on the utility of SABR in early-stage small-cell lung cancer and on SRS for non-malignant conditions, such as dural arteriovenous fistulas (for which he led the ISRS Practice Guidelines), vestibular schwannomas, cavernous malformations, and trigeminal neuralgia, among others. In addition, he has assessed the potential benefit of more aggressive radiation therapy approaches for glioblastoma and meningiomas and optimal treatment approaches for oropharyngeal cancers. Dr. Singh has presented at multiple national and international conferences and has more than 75 peer-reviewed publications in numerous medical journals, including JAMA Oncology, Cancer, International Journal of Radiation Oncology - Biology - Physics, Radiotherapy & Oncology, Oral Oncology, Neurosurgery, Journal of Neurosurgery, Journal of Neuro-Oncology, and Neuro-Oncology Advances.